CCS
MJN

Crosspoint Capital Strategies’s Mead Johnson Nutrition Company MJN Stock Holding History

Crosspoint Capital Strategies’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-300
Closed -$24K – 966
2015
Q4 		$24K Sell
300
-1,504
-83% -$118K 0.01% 562
2015
Q3 		$127K Buy
1,804
+4
+0.2% +$329 0.15% 144
2015
Q2 		$162K Buy
+1,800
New +$174K 0.05% 219

Other funds holding MJN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Crosspoint Capital Strategies's MJN Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Mead Johnson Nutrition Company (MJN) in Q1 2016, closing a stake of 300 shares — an estimated $24K sold.

Crosspoint Capital Strategies first reported a position in MJN in Q2 2015 and held it in 3 quarters. The position peaked at $162K in Q2 2015. 562 funds tracked by Wall St. Rank hold MJN as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Mead Johnson Nutrition Company position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 300 Mead Johnson Nutrition Company shares in Q1 2016, an estimated $24K.
  • Crosspoint Capital Strategies first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 3 quarters.
  • Crosspoint Capital Strategies's Mead Johnson Nutrition Company position peaked at $162K in Q2 2015.
  • 562 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.